   
  
G/MA/QR/N/BRA/2/Add.1  
 
3 June 2020 
(20-3970) Page: 1/3 
Committee on Market Access  Original: English  
 
 
 NOTIFICATION PURSUANT TO THE DECISION ON NOTIFICATION  PROCEDURE S 
FOR QUANTITATIVE RESTRICTIONS (G/L/59/REV.1)  
 BRAZIL 
Addendum  
The following communication, dated 29 May 2020, is being circulated at the request of the delegation 
of Brazil . 
 
A. Notifying Member : Brazil  
B. Date of notification:  27 May 2020  
C. First time notification:  
 Yes 
 No, last notification was made in (doc. symbol ): G/MA/QR/N//BRA/ 2 
D. Type of notification:  
 1. Complete (i.e. notification of all quantitative restrictions in force ) 
 2. Changes to a notification previously made in (doc symbol) which are of the following 
nature :  
  2.1 Introduction of new restrictions, as listed in Section 1. 
  2.2 Elimination of restrictions, as described in G below . 
  2.3 Modification of a previously notified restriction, as described in Section 1. 
 3. Reverse notification of restrictions maintain ed by (Member ):  
E. The notification provides information for the follo wing biennial period 
(e.g.  2012 -2014): 2018-2020 and relates to restrictions in force as of 13.05.2020  
F. This notification contains information* relating to:  
 Section 1:  List of quantitative restrictions that are currently in force . 
 Section 2:  Cross -reference to other WTO notifications wi th information on quantitative 
restrictions that are currently in force and additional information . 
G. Comments of a general nature, including a description of the elimination of 
restrictions notified under D.2.2 and the date they ceased to be in force.  
 Brazil is notifying measures adopted in the context of the Covid -19 pandemic.  
 
 
 
* In English  only.  
  G/MA/QR/N/BRA/2/Add.1  
 
- 2 - Section 1: List of quantitative restrictions that are currently in force  
QR 
No. General 
description of 
the restriction  Type of 
restriction  Tariff line 
code(s) 
affected, 
based on  
HS 2017  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  Administration, 
modification of 
previously notified 
measures, and other 
comments  
 1 2 3 4 5 6 7 
1 Export 
prohibition of 
medical, 
hospital and 
hygiene 
products 
essential to 
fighting the 
coronavirus 
epidemic in 
Brazil.  CP - X 
 39262000, 
39269090, 
40151100, 
40151900, 
62101000, 
62102000, 
62103000, 
63079010, 
90049020, 
90181980, 
90192030, 
90192090, 
94029020  Medical, hospital 
and hygiene 
products.  Article XI:2(a) of the 
GATT  Law Nº 13.993, in 
force from 24 April  
2020.  N/A 
2 Special export 
license for 
products 
essential in 
combatting 
COVID -19. NAL-X 22072019, 
29349934, 
38089419, 
38089429, 
38210000, 
38220090, 
39262000, 
39269040, 
39269090, 
40151100, 
40151900, 
56012299, 
62101000, 
62102000, 
62103000, 
62104000, 
62105000, 
63079010, 
63079090, 
65050 022, 
73262000, 
90049020, 
90049090, Medical, hospital 
and hygiene 
products  Article XI:2(a) of the 
GATT  Portaria SECEX nº 
16/2020, in force 
from 18 March 
2020.  N/A 
  
  G/MA/QR/N/BRA/2/Add.1  
 
- 3 - QR 
No. General 
description of 
the restriction  Type of 
restriction  Tariff line 
code(s) 
affected, 
based on  
HS 2017  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  Administration, 
modification of 
previously notified 
measures, and other 
comments  
 1 2 3 4 5 6 7 
90183922, 
90183923, 
90183924, 
90183991, 
90183999, 
90189010, 
90192010, 
90192030, 
90192040, 
90200010, 
90200090, 
90251110  and 
90272021  
3 Prior 
authorization 
for the export of 
certain 
pharmaceutical 
products 
essential in 
combatting 
COVID -19 NAL-X 29322000, 
29329999, 
29337990, 
29339959, 
29349999,  
30019090,  
30039033,  
30039069,  
30049059, 
30049069, 
30049099 and 
30049099  Pharmaceuticals  Article XI:2(a) of the 
GATT  Brazilian Health 
Regulatory 
Agency’s 
Collegiate Board 
Resolution nº 
352/2020, in force 
from March 20th, 
2020, as revised 
by the Brazilian 
Health Regulatory 
Agency’s 
Collegiate Board 
Resolution nº 381, 
from 13 May  
2020.  N/A 
__________  